The impact of SMARCA4 loss in non-small cell lung cancer therapy
This case report explores the therapeutic impact of SMARCA4 loss in a 63-year-old female patient with a history of smoking, hypertension, hypercholesterolemia, and prior surgeries for breast and pancreatic carcinomas, who presented with a new pulmonary nodule. On February 23, 2024, a CT scan identif...
Saved in:
Main Authors: | Mariano Lombardi, Marianna D'Ercole, Valeria Midolo De Luca, Matteo Chiari, Lorenzo Spaggiari, Luca Bertolaccini |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024171599 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brief Report: Clinical Characteristics and Outcomes of Patients With Thoracic SMARCA4-Deficient Undifferentiated Tumors
by: Alissa J. Cooper, MD, et al.
Published: (2025-01-01) -
First-line combination therapy of immunotherapy plus anti-angiogenic drug for thoracic SMARCA4-deficient undifferentiated tumors in AIDS: a case report and review of the literature
by: Xiaoling Wei, et al.
Published: (2025-01-01) -
SMARCA4 deficiency in small cell lung cancer: A case report and narrative review of the literature
by: Andreas M. Matthaiou, et al.
Published: (2025-01-01) -
SMARCA4-related Coffin-Siris syndrome in newborn: a case report and literature review
by: Yuqian Wang, et al.
Published: (2025-01-01) -
Unveiling the immunomodulatory dance: endothelial cells’ function and their role in non-small cell lung cancer
by: Sophia Daum, et al.
Published: (2025-01-01)